MCM
GOSS icon

Masters Capital Management’s Gossamer Bio GOSS Stock Holding History

Masters Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-700,000
Closed -$8.69M – 66
2020
Q3 		$8.69M Buy
700,000
+100,000
+17% +$1.33M 0.58% 39
2020
Q2 		$7.8M Buy
+600,000
New +$7.55M 0.88% 37

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Masters Capital Management's GOSS Position: Q4 2020 in Review

Masters Capital Management sold out of Gossamer Bio (GOSS) in Q4 2020, closing a stake of 700,000 shares — an estimated $8.69M sold.

Masters Capital Management first reported a position in GOSS in Q2 2020 and held it in 2 quarters. The position peaked at $8.69M in Q3 2020. 122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

  • Masters Capital Management reported no remaining Gossamer Bio position as of Q4 2020 after selling out during the quarter.
  • Masters Capital Management sold 700,000 Gossamer Bio shares in Q4 2020, an estimated $8.69M.
  • Masters Capital Management first reported a position in Gossamer Bio in Q2 2020 and held it in 2 quarters.
  • Masters Capital Management's Gossamer Bio position peaked at $8.69M in Q3 2020.
  • 122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on Masters Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.